ETrade Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,173
| Closed | -$562K | – | 932 |
|
|
2020
Q1 | $562K | Sell |
3,173
-1,830
| -37% | -$345K | 0.01% | 439 |
|
|
2019
Q4 | $956K | Sell |
5,003
-5,261
| -51% | -$949K | 0.02% | 370 |
|
|
2019
Q3 | $1.73M | Sell |
10,264
-26,162
| -72% | -$4.26M | 0.04% | 229 |
|
|
2019
Q2 | $6.1M | Buy |
36,426
+4,006
| +12% | +$555K | 0.16% | 66 |
|
|
2019
Q1 | $4.75M | Buy |
32,420
+10,248
| +46% | +$1.49M | 0.14% | 78 |
|
|
2018
Q4 | $2.96M | Sell |
22,172
-3,318
| -13% | -$544K | 0.1% | 116 |
|
|
2018
Q3 | $4.86M | Buy |
25,490
+413
| +2% | +$75.9K | 0.14% | 82 |
|
|
2018
Q2 | $4.18M | Buy |
25,077
+1,075
| +4% | +$173K | 0.13% | 83 |
|
|
2018
Q1 | $4.04M | Buy |
24,002
+7,670
| +47% | +$1.29M | 0.13% | 85 |
|
|
2017
Q4 | $2.67M | Buy |
16,332
+10,691
| +190% | +$1.92M | 0.09% | 133 |
|
|
2017
Q3 | $1.16M | Buy |
5,641
+327
| +6% | +$76K | 0.04% | 297 |
|
|
2017
Q2 | $1.29M | Sell |
5,314
-1,040
| -16% | -$244K | 0.05% | 210 |
|
|
2017
Q1 | $1.52M | Buy |
6,354
+1,242
| +24% | +$289K | 0.06% | 183 |
|
|
2016
Q4 | $1.07M | Sell |
5,112
-1,800
| -26% | -$373K | 0.05% | 218 |
|
|
2016
Q3 | $1.59M | Buy |
6,912
+1,073
| +18% | +$262K | 0.08% | 156 |
|
|
2016
Q2 | $1.35M | Buy |
5,839
+1,831
| +46% | +$422K | 0.07% | 161 |
|
|
2016
Q1 | $1.07M | Buy |
4,008
+1,003
| +33% | +$287K | 0.06% | 186 |
|
|
2015
Q4 | $939K | Buy |
3,005
+134
| +5% | +$39.9K | 0.06% | 196 |
|
|
2015
Q3 | $780K | Buy |
2,871
+889
| +45% | +$273K | 0.05% | 216 |
|
|
2015
Q2 | $601K | Buy |
1,982
+387
| +24% | +$115K | 0.04% | 262 |
|
|
2015
Q1 | $474K | Buy |
1,595
+191
| +14% | +$54.5K | 0.03% | 294 |
|
|
2014
Q4 | $362K | Sell |
1,404
-47
| -3% | -$11.7K | 0.02% | 367 |
|
|
2014
Q3 | $350K | Sell |
1,451
-32
| -2% | -$7.16K | 0.02% | 332 |
|
|
2014
Q2 | $330K | Buy |
1,483
+37
| +3% | +$7.66K | 0.02% | 291 |
|
|
2014
Q1 | $297K | Buy |
1,446
+1,390
| +2,482% | +$275K | 0.02% | 272 |
|
|
2013
Q4 | $9K | Buy |
56
+43
| +331% | +$6.72K | ﹤0.01% | 725 |
|
|
2013
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 862 |
|
|
2013
Q2 | $2K | Buy |
+13
| New | +$1.47K | ﹤0.01% | 808 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
ETrade Capital Management's AGN Position: Q2 2020 in Review
ETrade Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,173 shares — an estimated $562K sold.
ETrade Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.1M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- ETrade Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- ETrade Capital Management sold 3,173 Allergan plc shares in Q2 2020, an estimated $562K.
- ETrade Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- ETrade Capital Management's Allergan plc position peaked at $6.1M in Q2 2019.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on ETrade Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.